Skip to main content

Abstract

The purpose of this chapter is not to give a comprehensive overview of all aspects of fat and carbohydrate metabolism but to focus on glucose intolerance, its possible causes and the possible relationship with changes in fat metabolism. Facts with regard to metabolic disorders in liver disease are accumulating rapidly but the mechanisms involved are far from understood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. C. M. Leevy, C. M. Ryan, and J. C. Fineberg, Diabetes mellitus and liver dysfunction: etiologic and therapeutic considerations, Am. J. Med. 8: 290 (1950).

    Article  PubMed  CAS  Google Scholar 

  2. P. K. Bondy, Some metabolic anormalities in liver disease, Am. J. Med. 24: 428 (1958).

    Article  PubMed  CAS  Google Scholar 

  3. R. Hed, Clinical studies in chronic alcoholism. I. Incidence of diabetes mellitus in portal cirrhosis, Acta Med. Scand. 162: 189 (1958).

    Article  PubMed  CAS  Google Scholar 

  4. J. P. Felber, P. Magnenat, and A. Vannotti, Tolérance au glucose diminuée et réponse insulinique élevée dans la cirrhose, Schweiz. Med. Wschr 97: 1537 (1967).

    PubMed  CAS  Google Scholar 

  5. J. R. Collins and O. B. Crofford, Glucose intolerance and insulin resistance in patients with liver disease, Arch. Int. Med. 124: 142 (1969).

    Article  CAS  Google Scholar 

  6. J. Marco, J. Diego, M. L. Villanueva, M. Diaz-Fierros, I. Valverde, and J. M. Segovia, Elevated plasma glucagon levels in cirrhosis of the liver, New Engl. J. Med. 89: 1107 (1973).

    Article  Google Scholar 

  7. R. Sherwin, P. Joshi, R. Hendler, Hyperglucagonemia in Laennec’s cirrhosis. The role of portal-systemic shunting, New Engl. J. Med. 290: 239 (1974).

    Article  PubMed  CAS  Google Scholar 

  8. R. S. Sherwin, M. Fisher, J. Bessoff, N. Snyder, R. Hendler, H. O. Conn,and P. Felig, Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon, Gastroenterology 74: 1224 (1978).

    PubMed  CAS  Google Scholar 

  9. A. Mortiaux and A. M. Dawson, Plasma free fatty acid in liver disease, Gut 2: 304 (1961).

    Article  PubMed  CAS  Google Scholar 

  10. K. G. M. M. Alberti and D. G. Johnston, Carbohydrate Metabolism in Liver Disease in:“Liver and Biliary Disease, Pathophysiology, Diagnosis, Management” R. Wright, ed., W. B. Saunders Company Ltd., London, Philadelphia, Toronto (1979).

    Google Scholar 

  11. H. Ring-Larsen, B. Hesse, J. H. Henriksen,and N. J. Christensen, Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: Plasma norepinephrine concentration, hepatic extraction and renal release Hepatology 2: 304 (1982).

    Article  PubMed  CAS  Google Scholar 

  12. O. Riggio, M. Merli, C. Cangiano, R. Capocaccia, A. Cascino, A. Lala, F. Leonetti, M. Mauceri, M. Pepe, F. Rossi-Fanelli, M. Savioli, G. Tamburrano,and L. Capocaccia, Glucose intolerance in liver cirrhosis, Metabolism 31: 627 (1982).

    Article  PubMed  CAS  Google Scholar 

  13. R. S. Sherwin, Effect of epinephrine on fuel metabolism in man: Role in the response to stress. Proceedings of the 4th Espen Congress, Vienna. In press (1982).

    Google Scholar 

  14. P. R. Black, D. C. Brooks, P. Q. Bessey, R. R. Wolfe, and D. W. Wilmore, Mechanisms of insulin resistance following injury, Ann. Surg. 196: 420 (1982).

    Article  PubMed  CAS  Google Scholar 

  15. D. C. Deibert and R. A. DeFronzo, Epinephrine-induced insulin resistance in man, J. Clin. Invest. 65: 717 (1980).

    Article  PubMed  CAS  Google Scholar 

  16. J. E. Liljenquist and D. Rabin, Lack of a role for glucagon in the disposal of an oral glucose load in normal man, J. Clin. Endocrinol. Metab. 49: 937 (1979).

    Article  PubMed  CAS  Google Scholar 

  17. R. H. Unger and L. Orci, Role of glucagon in diabetes, Arch. Int. Med. 137: 482 (1977).

    Article  CAS  Google Scholar 

  18. H. N. Munro, D. Fernstrom,and R. J. Wurtman, Insulin, plasma amino acid imbalance and hepatic coma, Lancet 1: 722 (1975).

    Article  PubMed  CAS  Google Scholar 

  19. C. O. Record, R. A. Chase, K. G. M. M. Alberti,and R. Williams, Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose, Clin. Sci. Mol. Med. 49: 473 (1975).

    PubMed  CAS  Google Scholar 

  20. K. G. M. M. Alberti, C. O. Record, D. H. Williamson, and R. Wright, Metabolic changes in active chronic hepatitis, Clin. Sci. Mol. Med. 42: 591 (1972).

    CAS  Google Scholar 

  21. P. B. Soeters, G. Weir, A. M. Ebeid, and J. E. Fischer, Insulin, glucagon, portal systemic shunting and hepatic failure in the dog, J. Surg. Res. 23: 183 (1977).

    Article  PubMed  CAS  Google Scholar 

  22. P. Rous and L. D. Larimore, Relation of the portal blood to liver maintenance: A demonstration of liver atrophy condition on compensation, J. Exp. Med. 31: 600 (1920).

    Google Scholar 

  23. T. E. Starzi, K. Watanabe, and K. A. Porter, Effect of insulin, glucagon and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs, Lancet 1: 821 (1976).

    Article  Google Scholar 

  24. H. O. Conn, Ammonia tolerance as an index of portal-systemic collateral circulation in cirrhosis, Gastroenterology 41: 97 (1961).

    PubMed  CAS  Google Scholar 

  25. A. R. Burchell, A. H. Moreno, W. F. Panke, and T. F. Nealon, Hepatic artery flow improvement after portacaval shunt: a single haemodynamic clinical correlate, Ann. Surg. 184: 289 (1976).

    Article  PubMed  CAS  Google Scholar 

  26. P. J. Lefebvre and A. S. Luyckx, Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog, Metabolism 24: 1169 (1975).

    Article  PubMed  CAS  Google Scholar 

  27. S. C. Woods and D. Porte, Jr., Neural control of the endocrine pancreas, Physiol. Rev. 54: 596 (1974).

    PubMed  CAS  Google Scholar 

  28. L. Orci, A portrait of the pancreatic beta cell, Diabetologia 10: 163 (1974).

    Article  PubMed  CAS  Google Scholar 

  29. J. P. Palmer, D. P. Henry, J. W. Benson, D. G. Johnson, and J. W. Ensinck, Glucagon response to hypoglycemia in sympatectomized man, J. Clin. Invest. 57: 522 (1976).

    Article  PubMed  CAS  Google Scholar 

  30. J. Iversen, Adrenergic receptors and the secretion of glucagon and insulin from the isolated perfused canine pancreas., J. Clin. Invest. 52: 2102 (1973).

    Article  PubMed  CAS  Google Scholar 

  31. J. E. Gerich, J. H. Karam, and P. H. Forsham, Stimulation of glucagon secretion by epinephrine in man, J. Clin. Endocrin. Metab. 37: 479 (1973).

    Article  CAS  Google Scholar 

  32. J. E. Gerich, M. Langlois, C. Noacco, V. Schneider, and P. H. Forsham, Adrenergic modulation of pancreatic glucagon secretion in man, J. Clin. Invest. 53: 1441 (1974).

    Article  PubMed  CAS  Google Scholar 

  33. E. J. Rayfield, D. T. George, H. L. Eichner, and T. H. Tsu, L-Dopa stimulation of glucagon secretion in man, New Engl. J. Med. 293: 589 (1975).

    Article  PubMed  CAS  Google Scholar 

  34. J. W. Ensinck, R. M. Walter, J. P. Palmer, R. G. Brodows, and R. G. Campbell, Glucagon responses to hypoglycemia in Adrenalectomized Man, Metabolism 25: 227 (1976).

    Article  PubMed  CAS  Google Scholar 

  35. J. P. Palmer, J. Halter, and P. L. Werner, Differential effect of isoproterenol on acute glucagon and insulin release in man, Metabolism 28: 237 (1979).

    Article  PubMed  CAS  Google Scholar 

  36. A. S. Luyckx and P. J. Lefebvre, Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids, Proc. Soc. Exp. Biol. Med. 133: 524 (1970).

    PubMed  CAS  Google Scholar 

  37. S. S. Andrews, S. A. Lopez, and W. G. Blackard, Effect of lipids on glucagon secretion in man, Metabolism 24: 35 (1975).

    Article  PubMed  CAS  Google Scholar 

  38. J. K. Wise, R. Hendler, and P. Felig, Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man, J. Clin. Invest. 52: 2774 (1973).

    Article  PubMed  CAS  Google Scholar 

  39. E. Holm, Personal communication.

    Google Scholar 

  40. M. R. Lunzer, S. P. Newman, A. G. Bernard, K. K. Manghani, S. P. V. Sherlock, and J. Ginsburg, Impaired cardiovascular responsiveness in liver disease, Lancet 2: 382 (1975).

    Article  PubMed  CAS  Google Scholar 

  41. D. G. Johnston, K. G. M. M. Alberti, O. K. Faber, and C. Binder, Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion? Lancet, January 1: 10 (1977).

    Google Scholar 

  42. D. G. Johnston, K. G. M. M. Alberti, R. Wright, G. Smith-Laing, A. M. Stewart, S. Sherlock, O. Faber,and C. Binder, C-peptide and insulin in liver disease, Diabetes 27 (Suppl. 1): 201 (1978).

    PubMed  CAS  Google Scholar 

  43. G. Smith-Laing, S. Sherlock, and O. K. Faber, Effects of spontaneous portal-systemic shunting on insulin metabolism, Gastroenterology 76: 685 (1979).

    PubMed  CAS  Google Scholar 

  44. A. I. Katz and A. H. Rubenstein, Metabolism of pro-insulin, insulin and C-peptide in the rat, J. Clin. Invest. 52: 1113 (1973).

    Article  PubMed  CAS  Google Scholar 

  45. R. W. Stoll, J. L. Touber, L. A. Menahan, and R. H. Williams, Clearance of porcine, insulin, pro-insulin and connecting peptides by the isolated rat liver, Proc. Soc. Exp. Biol. Med. 133: 894 (1970).

    PubMed  CAS  Google Scholar 

  46. C. Kúhl, O. K. Faber, P. Hornnes, and S. Jensen Lindkaer, Cpeptide metabolism and the liver, Diabetes 27 (Suppl. 1): 197 (1978).

    PubMed  Google Scholar 

  47. G. Oehler, H. Bleyl,and K. J. Matthes, Glucose tolerance and serum insulin in different chronic liver diseases. VI International Congress of Liver Diseases, Basel, October 15–17, Abstract no. 145 (1982).

    Google Scholar 

  48. P. Vannini, G. Forlani, G. Marchesini, and E. Pisi, Evaluation of insulin resistance in liver cirrhosis by means of the glucose clamp technique, Ital. J. Gastroenterol. 13: 255 (1981).

    Google Scholar 

  49. R. Taylor, R. Heine, J. Collins, K. G. M. Alberti, and O. F. W. James, No marked impairment of insulin binding to adipocytes in insulin resistant cirrhotics. VI International Congress of Liver Diseases. Basel, October 15–17, 1982. Abstract no. 193 (1982).

    Google Scholar 

  50. P. J. Randle, C. N. Hales, P. B. Garland, and E. A. Newsholme, The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet 1: 7285 (1963).

    Google Scholar 

  51. E. A. Newsholme and C. Start, Regulation of fat metabolism in liver. Introduction. in:“Regulation in Metabolism;’ Chapter 7. John Wiley, London, New York, Toronto (1974).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Soeters, P.B., de Boer, J.E.G., Oostenbroek, R.J., Janssen, M.A. (1984). Carbohydrate Metabolism in Liver Disease. In: Capocaccia, L., Fischer, J.E., Rossi-Fanelli, F. (eds) Hepatic Encephalopathy in Chronic Liver Failure. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4787-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4787-3_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4789-7

  • Online ISBN: 978-1-4684-4787-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics